drugset / Press release
Ultragenyx Announces Results from Phase 2 Study of Sialic Acid Extended-Release Treatment in Hereditary Inclusion Body Myopathy
2013-12-20 · Ultragenyx Pharmaceutical Inc · original ultragenyx.com ↗
Ultragenyx Announces Results from Phase 2 Study of Sialic Acid Extended-Release Treatment in Hereditary Inclusion Body Myopathy
The release as fetched from its publisher. ultragenyx.com ↗